Login / Signup

Immunogenicity of BNT162b2 mRNA SARS-CoV-2 vaccine in patients with psoriatic arthritis on TNF inhibitors.

Vincenzo VeneritoPasquale StefanizziMarco FornaroFabio CacciapagliaSilvio TafuriSimone PerniolaFlorenzo IannoneGiuseppe Lopalco
Published in: RMD open (2022)
Continuing TNFi in patients with PsA throughout the vaccination did not hamper immunogenicity.
Keyphrases
  • sars cov
  • prostate cancer
  • rheumatoid arthritis
  • respiratory syndrome coronavirus
  • radical prostatectomy
  • medical education
  • binding protein